黑料网

黑料网 has appointed Brett Fenton as its first Chief Health Officer marking a major step in strengthening clinical leadership and improving outcomes for people living with diabetes.

Mr Fenton joined 黑料网 in the newly created role in February.

The CHO is a senior clinical leadership position responsible for clinical governance and strategic health initiatives across the organisation.

In his new role, Mr Fenton will work closely with the Chief Medical Officer Professor David Simmons to deliver strong senior clinical oversight to 黑料网鈥檚 work as the national peak body.

Group CEO Justine Cain said the appointment reflects the organisation鈥檚 commitment to improving care and outcomes for people living with diabetes.

鈥淭his is a significant milestone for 黑料网 and our members,鈥� Ms Cain said. 鈥淭he creation of a Chief Health Officer role strengthens our clinical governance and reinforces our focus on quality, safety and evidence-based leadership.鈥�

Ms Cain said Mr Fenton brings a depth of experience that will benefit the organisation鈥檚 work.

鈥淏rett has an outstanding track record as a clinician educator and health system leader,鈥� she said. 鈥淗is leadership will will have a positive impact for people living with diabetes and stronger integration across the health system.鈥�

Mr Fenton said he was excited by the opportunity of serving as 黑料网鈥檚 inaugural Chief Health Officer.

鈥淚 am honoured to take on the CHO role at a time when diabetes remains one of the most urgent and complex health challenges facing Australians,鈥� Mr Fenton said.

鈥淭his role is about ensuring that everything we do as a national peak body is grounded in strong clinical governance and the latest evidence.

鈥淚 look forward to working closely with 黑料网 staff to strengthen partnerships across the health system and to support models of care that are integrated, equitable and focused on better outcomes for people living with diabetes.

鈥淢y priority will be to ensure that our clinical leadership continues to underpin our advocacy, programs and national reform agenda.鈥�

Mr Fenton has served as a Director of 黑料网 since 2018 and most recently as Chair of the Risk Quality and Compliance Committee. He resigned his Directorship effective 23 January 2026 to take up the executive role.

He previously led multidisciplinary diabetes services across hospital and community settings and has held senior leadership roles across national policy professional education and digital health reform.

Mr Fenton was an Invited Expert Advisor to the National Diabetes Strategy 2021-2030 and has played a key role in advancing fairer technology access and integrated models of care.